Ocz103-os

Other Medications

EU Experimental ES Not available 1 Clinical Trials

Description

Ocz103-os is an investigational medication currently being studied in clinical trials for colorectal cancer. It is being evaluated as a potential treatment option for patients with unresectable or metastatic colorectal cancer that has progressed after standard chemotherapy. In clinical trials, Ocz103-os is being used in combination with standard chemotherapy regimens like mFOLFOX6 or FOLFIRI. The goal of these trials is to assess the safety and effectiveness of adding Ocz103-os to standard treatment in this setting. It is not yet approved for use in colorectal cancer.

Mechanism of Action

Ocz103-os is designed to target cancer cells. It works by interfering with the function of specific molecules within the cancer cell, potentially leading to cell death or reduced growth. The specific molecular target and detailed mechanism of action are still under investigation in clinical trials.

Side Effects

As Ocz103-os is an investigational drug Its side effect profile is still being fully evaluated in ongoing clinical trials. The most informative trial (NCT01378143) is a Phase 2 study assessing safety and efficacy in combination with standard chemotherapy. Common side effects associated with the standard chemotherapy regimens used in the trial (like mFOLFOX6 or FOLFIRI) include nausea Vomiting Diarrhea Fatigue And potential effects on blood counts. Specific side effects related to Ocz103-os itself are being monitored closely in these trials.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT01378143 Phase 2
Archived
Using OCZ103-OS in Patients With Unresectable and Locally Recurrent or Metastatic Colorectal Cancer Undergoing Standard Chemotherapy
Canada

Quick Info

CategoryOther Medications
EU EMA StatusExperimental
ES Spain AccessNot available
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
785 trials
Leucovorin
Other Medications
646 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.